Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-047737
Filing Date
2026-02-12
Accepted
2026-02-12 08:07:48
Documents
70
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q bntc-20251231.htm   iXBRL 10-Q 1774150
2 EX-31.1 bntc-ex31_1.htm EX-31.1 17546
3 EX-31.2 bntc-ex31_2.htm EX-31.2 17486
4 EX-32.1 bntc-ex32_1.htm EX-32.1 10242
5 EX-32.2 bntc-ex32_2.htm EX-32.2 10202
6 GRAPHIC img266717061_0.jpg GRAPHIC 17217
7 GRAPHIC img266717061_1.jpg GRAPHIC 15672
8 GRAPHIC img266717061_2.jpg GRAPHIC 100718
9 GRAPHIC img266717061_3.jpg GRAPHIC 89283
  Complete submission text file 0001193125-26-047737.txt   7507148

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bntc-20251231.xsd EX-101.SCH 877865
73 EXTRACTED XBRL INSTANCE DOCUMENT bntc-20251231_htm.xml XML 1124120
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39267 | Film No.: 26623508
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)